ARDT moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend. In 15 of 17 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ARDT as a result. In 38 of 51 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for ARDT just turned positive on November 04, 2026. Looking at past instances where ARDT's MACD turned positive, the stock continued to rise in 13 of 18 cases over the following month. The odds of a continued upward trend are 72%.
The 10-day moving average for ARDT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +13.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARDT advanced for three days, in 90 of 123 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 50 of 85 cases where ARDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
ARDT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ARDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.807) is normal, around the industry mean (204.532). P/E Ratio (31.753) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.238) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SGRY advanced for three days, in 192 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on SGRY as a result. In 53 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for SGRY just turned positive on October 12, 2026. Looking at past instances where SGRY's MACD turned positive, the stock continued to rise in 30 of 43 cases over the following month. The odds of a continued upward trend are 70%.
SGRY moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SGRY crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The 50-day moving average for SGRY moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Aroon Indicator entered an Uptrend today. In 114 of 170 cases where SGRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 19 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
SGRY broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. SGRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.818) is normal, around the industry mean (204.532). P/E Ratio (-33.623) is within average values for comparable stocks, (21.572). SGRY's Projected Growth (PEG Ratio) (21.970) is very high in comparison to the industry average of (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.530) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
SGRY | ||
|---|---|---|
OUTLOOK RATING 1..100 | 47 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 92 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 88 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ARDT | SGRY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 72% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 67% |
| Advances ODDS (%) | 3 days ago 73% | 2 days ago 70% |
| Declines ODDS (%) | 9 days ago 73% | 14 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 59% | 2 days ago 67% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARDT’s FA Score shows that 1 FA rating(s) are green while SGRY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARDT’s TA Score shows that 6 TA indicator(s) are bullish while SGRY’s TA Score has 7 bullish TA indicator(s).
ARDT (@Hospital/Nursing Management) experienced а +53.12% price change this week, while SGRY (@Hospital/Nursing Management) price change was +15.56% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.75%. For the same industry, the average monthly price growth was +0.37%, and the average quarterly price growth was +10.84%.
SGRY is expected to report earnings on Mar 01, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that ARDT and HCA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARDT and HCA's prices will move in lockstep.
| Ticker / NAME | Correlation To ARDT | 1D Price Change % | ||
|---|---|---|---|---|
| ARDT | 100% | -0.22% | ||
| HCA - ARDT | 32% Poorly correlated | -0.09% | ||
| ADUS - ARDT | 30% Poorly correlated | +3.16% | ||
| UHS - ARDT | 30% Poorly correlated | -0.89% | ||
| PNTG - ARDT | 28% Poorly correlated | +1.32% | ||
| THC - ARDT | 27% Poorly correlated | +0.44% | ||
More | ||||
A.I.dvisor tells us that SGRY and ASTH have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGRY and ASTH's prices will move in lockstep.
| Ticker / NAME | Correlation To SGRY | 1D Price Change % | ||
|---|---|---|---|---|
| SGRY | 100% | +1.06% | ||
| ASTH - SGRY | 30% Poorly correlated | -4.71% | ||
| CYH - SGRY | 27% Poorly correlated | -3.98% | ||
| ARDT - SGRY | 27% Poorly correlated | -0.22% | ||
| THC - SGRY | 27% Poorly correlated | +0.44% | ||
| LFST - SGRY | 26% Poorly correlated | -0.27% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OPPE | 60.06 | 0.13 | +0.22% |
| WisdomTree European Opportunities Fund (OPPE) | |||
| ODDZ | 20.39 | N/A | N/A |
| Corgi Sports Betting & Gambling ETF (ODDZ) | |||
| NELS | 28.46 | -0.05 | -0.17% |
| Nelson Select ETF (NELS) | |||
| DDXX | 27.83 | -0.11 | -0.41% |
| Defined Duration 20 ETF (DDXX) | |||
| IBTK | 19.12 | -0.09 | -0.49% |
| iShares iBonds Dec 2030 Term Treasury ETF (IBTK) | |||